Samsung Biologics Validates Carbon Footprint System Against Global Standards

Event summary

  • Samsung Biologics' product carbon footprint (PCF) system validated by DNV against ISO 14067 and PAS 2050 standards on February 6, 2026.
  • Validation covers data input, conversion, and output processes for biopharmaceutical manufacturing.
  • Company aims to enhance transparency and comparability of carbon footprint data across the value chain.
  • Samsung Biologics received a Platinum rating from EcoVadis, placing it in the top 1% globally for sustainability management.

The big picture

Samsung Biologics' validation of its PCF system underscores the growing importance of carbon transparency in the biopharmaceutical sector. As sustainability becomes a key differentiator, this move aligns with broader industry trends toward standardized carbon accounting and net-zero commitments. The company's Platinum EcoVadis rating further solidifies its position as a leader in sustainable manufacturing practices.

What we're watching

Industry Adoption
How quickly other CDMOs will adopt similar validated PCF systems to meet evolving client expectations.
Regulatory Compliance
Whether the validation will position Samsung Biologics favorably under upcoming sustainability regulations.
Operational Impact
The pace at which the validated PCF system will influence manufacturing decisions and client partnerships.